Navin Robert Pinto MD
Pediatric Solid Tumor Oncology
Associate Professor of Pediatrics
Join to View Full Profile
4800 Sand Point Way NESeattle, WA 98105
Dr. Pinto is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of ChicagoFellowship, Pediatric Hematology/Oncology, 2008 - 2011- University of ChicagoResidency, Pediatrics, 2005 - 2008
Saint Louis University School of MedicineClass of 2005
Certifications & Licensure
CO State Medical License 2023 - 2027
WA State Medical License 2015 - 2024
ID State Medical License 2021 - 2023
IL State Medical License 2005 - 2017
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Phase 2 Study of Inhaled Lipid Cisplatin in Pulmonary Recurrent Osteosarcoma Start of enrollment: 2012 Aug 01
- Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery Start of enrollment: 2014 Jul 11
- Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer Start of enrollment: 2019 Sep 27
Roles: Contact
- Join now to see all
Publications & Presentations
PubMed
- 46 citationsLorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results.Kelly C Goldsmith, Julie R Park, Kimberly Kayser, Jemily Malvar, Yueh-Yun Chi
Nature Medicine. 2023-05-01 - 2 citationsImpact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without MYCN Amplification: A...Navin Pinto, Arlene Naranjo, Xiangming Ding, Fan F Zhang, Emily Hibbitts
Clinical Cancer Research. 2023-04-14 - 9 citationsClinical Targeted Next-Generation Panel Sequencing RevealsAmplification Is a Poor Prognostic Factor in Osteosarcoma.Amanda E Marinoff, Liam F Spurr, Christina Fong, Yvonne Y Li, Suzanne J Forrest
JCO Precision Oncology. 2023-03-01
Press Mentions
- HAPPENING NOW: Life-Saving Dodgeball @ RiverviewSeptember 25th, 2021
Pediatric Cancer in Yakima Valley: 'Sometimes You Want to Collapse, but You Can't'October 6th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
